Compare DuPont de Nemours Inc (DD) vs Elevance Health Inc. Common Stock (ELV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DuPont de Nemours Inc vs Elevance Health Inc. Common Stock — how do they compare? DuPont de Nemours Inc trades at $131.49 (market cap $17.89B), while Elevance Health Inc. Common Stock trades at $401.99 (market cap $86.95B). The key difference: Elevance Health Inc. Common Stock is far larger — about 4.9× DuPont de Nemours Inc's market cap, and DuPont de Nemours Inc pays the higher dividend (1.81%). Which is the better fit depends on your goals.
| DD | ELV | |
|---|---|---|
Market Cap | $17.89B | $86.95B |
Volume | 816,409 | 782,706 |
Sector | Basic Materials | Health |
52-Week High | $154.59 | $426.79 |
52-Week Low | $92.49 | $280.74 |
Typical Hold Time | 89 Days | — |
Enterprise Value | $19.28B | $107.76B |
Dividend Yield | 1.81% | 1.72% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DuPont (DD) trades at $131.08, down 1.65% on the day, with a neutral technical signal and mixed fundamentals. Recent earnings have consistently beaten estimates, but 2025 saw a net loss of $779 million on revenue of $6.85 billion. The company maintains innovation with new product launches like the Sugar Separation Advisor and Tyvek with Renewable Attribution, while facing headwinds from legal settlements and uneven demand.
The outlook is cautious; analyst consensus is bullish with a 58.54% buy rating but a price target of $95.00 below the current price. Key opportunities include margin expansion in growth markets, while risks involve PFAS litigation costs, volatile cash flows, and execution challenges in a competitive landscape.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DuPont de Nemours Inc
DuPont is a diversified global specialty chemicals company created in 2019 as a result of the DowDuPont merger and subsequent separations. Its portfolio includes specialty chemicals and downstream products that serve the electronics and communication, automotive, construction, safety and protection, and water management industries. DuPont benefits from the ability to produce patented specialty chemicals that command pricing power. Noteworthy products include Kevlar, Tyvek, and Nomex have evolved over time to enable a wide range of applications across multiple industries.
Read more on DD →About Elevance Health Inc. Common Stock
Elevance Health provides health plans and healthcare services. Its offerings include medical, behavioral health, pharmacy, dental, vision, and complex-care solutions, including through the Carelon business.
Read more on ELV →
